Australasian journal on ageing · 2012
Characteristics of older and younger patients with suspected paracetamol toxicity.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kane Alice, Mitchell Sarah J, Carroll Peter R, Matthews Slade, Hilmer Sarah N
Аннотация
AIM: The aim of this study was to compare the characteristics of older and younger patients with suspected paracetamol toxicity.
METHODS: A retrospective audit of the medical records of older (≥65 years, n = 25) and younger (20-30 years, n = 50) patients with a detectable paracetamol level at a Sydney hospital.
RESULTS: Older patients showed a different clinical pattern of suspected paracetamol toxicity and were more likely than younger patients to have multifactorial elevation of liver function tests. Additionally, older age was more likely to be associated with chronic therapeutic paracetamol dosing (71% older, 6% younger, P < 0.001), or with accidental toxic exposure (90% older, 29% younger, P < 0.001), while younger patients were more likely to have a deliberate high-dose exposure (10% older, 71% younger, P < 0.001).
CONCLUSIONS: The age-related differences in paracetamol exposure, paracetamol levels and liver function tests described in this population should be considered when ordering and interpreting paracetamol levels.
METHODS: A retrospective audit of the medical records of older (≥65 years, n = 25) and younger (20-30 years, n = 50) patients with a detectable paracetamol level at a Sydney hospital.
RESULTS: Older patients showed a different clinical pattern of suspected paracetamol toxicity and were more likely than younger patients to have multifactorial elevation of liver function tests. Additionally, older age was more likely to be associated with chronic therapeutic paracetamol dosing (71% older, 6% younger, P < 0.001), or with accidental toxic exposure (90% older, 29% younger, P < 0.001), while younger patients were more likely to have a deliberate high-dose exposure (10% older, 71% younger, P < 0.001).
CONCLUSIONS: The age-related differences in paracetamol exposure, paracetamol levels and liver function tests described in this population should be considered when ordering and interpreting paracetamol levels.